Africa: Refusal to Waive IP Rights for Covid-19 Vaccines Violates Human Rights - Experts

(File photo)
31 August 2023

UN rights experts called on States in the global North on Thursday to forgo intellectual property rights on COVID-19 vaccines and treatments in the name of human rights.

The UN Committee on the Elimination of Racial Discrimination (CERD) adopted a decision under its "early warning and urgent action" procedures, stating that developed countries' "persistent refusal" to waive COVID-19 vaccine IP rights - such as patents and trademarks - violated non-discrimination guarantees under international human rights law.

CERD is one of the UN's human rights treaty bodies. It monitors the implementation of the Convention on the Elimination of All Forms of Racial Discrimination by its 182 State parties and is composed of 18 independent experts serving in their personal capacity.

Developing world left behind

The Committee said it was addressing in particular countries such as Germany, Switzerland, the United Kingdom and the United States, who were all State parties to the Convention and had developed IP-protected COVID-19 vaccines, treatments and healthcare technologies.

Quoting the latest data from the UN World Health Organization (WHO), the Committee pointed out that while some 32 per cent of the global population have received at least one COVID-19 booster, in developing countries such as Gabon, Papua New Guinea, Burundi and Madagascar, that proportion stands at less than one per cent.

'Disproportionate impacts'

The Committee insisted that COVID-19 remained a serious public health issue with devastating negative impacts that are falling "disproportionately" on individuals and groups vulnerable to racial discrimination - in particular people of African or Asian descent, ethnic minorities, Roma communities and Indigenous Peoples.

In an interview with UN News, CERD chairperson Verene Shepherd underscored the "high levels of morbidity and mortality" affecting these groups. "We can't allow this to go unattended", she said.

Suspend IP rights in health crises

The Committee's experts urged States to incorporate a mechanism that commits governments to suspend intellectual property rights in a health crisis, in the draft pandemic preparedness treaty currently under negotiation at the WHO.

They called on States parties in the global North to support poorer countries' healthcare capacity with resources and to enable vaccines, relevant medicines and other necessary equipment and supplies "to be available to all".

The right to health

The Committee is also in the process of preparing new guidance, under the form of a "general recommendation", on racial discrimination and the enjoyment of the right to health.

Ms. Shepherd said that the COVID-19 pandemic was a direct trigger for this project. She stressed that a link had to be made between the historic injustices of slavery and colonialism which "remain largely unaccounted for today" and the low level of attention paid to the health of people of African descent, Indigenous Peoples and ethnic minorities.

The issue was an urgent action item for the Committee, she said, and the first draft adopted in April built upon the "evidence-based link between racial discrimination as a structural social determinant - as recognized by WHO - and the right to health".

The Committee was gathering contributions from a wide variety of stakeholders to prepare a final version of the guidance, she said.

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.